Market Cap 581.73M
Revenue (ttm) 8.33M
Net Income (ttm) -89.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,072.03%
Debt to Equity Ratio 0.77
Volume 4,281,600
Avg Vol 3,674,424
Day's Range N/A - N/A
Shares Out 214.66M
Stochastic %K 43%
Beta 0.90
Analysts Strong Sell
Price Target $7.35

Latest News on TSHA

Taysha Gene Therapies Is Showing Promise For Rett Syndrome

Jan 27, 2025, 7:53 PM EST - 4 months ago

Taysha Gene Therapies Is Showing Promise For Rett Syndrome


Taysha Gene Therapies, Inc. (TSHA) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 12:08 PM EDT - 10 months ago

Taysha Gene Therapies, Inc. (TSHA) Q2 2024 Earnings Call Transcript


What's Going On With Taysha Gene Therapies Stock Tuesday?

Jun 18, 2024, 11:42 AM EDT - 1 year ago

What's Going On With Taysha Gene Therapies Stock Tuesday?


Taysha Gene Therapies: TSHA-102's Potential Is A 'Buy'

Nov 3, 2023, 7:41 PM EDT - 1 year ago

Taysha Gene Therapies: TSHA-102's Potential Is A 'Buy'